FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma Cilta-cel, ide-cel win support despite concerns about early mortality risk Mar 16, 2024
FDA Approves First CAR-T for Chronic Lymphocytic Leukemia Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL Mar 15, 2024
FDA Tries to Close the Lid on Poop Transplant Company Fecal microbiota transplant business needs a BLA or IND to operate, agency says Mar 15, 2024
New PD-1 Inhibitor Approved for Esophageal Cancer Tislelizumab improved median OS from 6.3 months with chemotherapy to 8.6 months Mar 15, 2024
FDA Approves First-Ever Drug for Serious Liver Condition Resmetirom indicated for NASH patients with liver scarring Mar 14, 2024
FDA Panel Endorses Imetelstat for MDS-Related Anemia By 12-2 vote, members find improvement in transfusion independence outweighs risk Mar 14, 2024
Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myeloma FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting Mar 14, 2024
Don't Drive on These Meds; Darryl Strawberry's Heart Attack; CDC Airport Screening Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Mar 13, 2024
FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment Mar 12, 2024
Banning Gain-of-Function Research Would Do Far More Harm Than Good A House-passed bill could stifle the potential for revolutionary medical advancements Mar 11, 2024
Benzene Can Form in Acne Treatments, Lab Finds Benzoyl peroxide formulations can break down into the carcinogen Mar 07, 2024
First-Line Nivolumab Plus Chemo Approved for Bladder Cancer Combination reduced risk of death by 22% Mar 07, 2024
10,000 Steps Lowers Death Risk; Obesity Drug Beats Wegovy; Lead in Cinnamon Warning Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Mar 07, 2024
FDA Clears First OTC Continuous Glucose Monitor Dexcom's Stelo system available without a prescription by the summer Mar 06, 2024
FDA OKs First Interchangeable Biosimilars for Denosumab New products will carry all the same indications as Prolia and Xgeva, though launch date unclear Mar 06, 2024
FDA Says Eating Yogurt May Reduce Diabetes Risk Products will be allowed to carry claims as long as they don't mislead consumers Mar 04, 2024
Zyn Nicotine Pouches Are All Over TikTok, Sparking Debate Experts wrestle with their potential benefits and risks Mar 04, 2024
FDA OKs Amivantamab as First-Line Lung Cancer Treatment Bispecific drug lands full approval for NSCLCs with EGFR exon 20 insertion mutations Mar 04, 2024
FDA Announces End to 'Forever Chemicals' in U.S. Food Packaging PFAS chemicals have been tied to a number of health issues Feb 28, 2024
Abdominal Fat and Dementia; Mask Ban Lawsuit Tossed; FDA Rejects Psych Drug Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Feb 28, 2024
Amy Schumer's Diagnosis; FDA Yanks Cancer Drug; Nursing Student Murdered Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Feb 26, 2024
FDA Authorized Florida's Drug Importation Plan. Naysayers Are Balking. It's not an efficient solution Feb 24, 2024
FDA OKs Device for Pediatric Kidney Injury Due to Sepsis The device was granted a Humanitarian Device Exemption approval Feb 23, 2024
FDA: Don't Use Smartwatches, Smart Rings for Blood Glucose Measurements Noninvasive devices that don't pierce the skin can give inaccurate measurements Feb 22, 2024
Medication Abortion Via Telehealth Safe and Effective, Study Finds No difference in results between patients who received care via video vs secure text messaging Feb 20, 2024
FDA OKs First Cellular Therapy for Melanoma Lifileucel approved as treatment for advanced melanoma after anti-PD-1 and targeted therapy Feb 16, 2024
First Drug OK'd for Reducing Allergic Reactions From Multiple Foods 68% of patients who received omalizumab tolerated a single dose of peanut after 16-20 weeks Feb 16, 2024
Tepotinib Gains Full Approval for Metastatic NSCLC Agency converts accelerated approval for subset with MET exon 14 mutations Feb 16, 2024
Lawmakers Clash Over COVID Vaccine Safety at House Hearing Purpose of CDC's VAERS reporting system debated Feb 15, 2024
COVID's Latest Adaptation: It Has Lulled Us to Sleep My doctor's refusal to prescribe "just-in-case" Paxlovid speaks volumes Feb 15, 2024
FDA Approves First Drug for Severe Frostbite Vasodilator iloprost significantly cut the risk of amputations in trial Feb 14, 2024
FDA Advisors Nearly All Aboard the TriClip Train for Tricuspid Regurgitation Committee voted 13-1 that the benefits of the TEER device outweigh the risks in certain patients Feb 14, 2024
New First-Line Option for Pancreatic Cancer Approved Liposomal irinotecan-based regimen gets FDA greenlight for metastatic disease Feb 13, 2024
FDA Reviewers Skeptical on TriClip for Tricuspid Regurgitation Tricuspid valve repair system is up for advisory committee scrutiny on Tuesday Feb 12, 2024
Sleep Apnea Smartwatch Feature Gets FDA Authorization Software is first of its kind to receive agency greenlight, set to roll out this year Feb 12, 2024
FDA Approves First Oral Option for Eosinophilic Esophagitis Fixed-duration course of corticosteroid indicated for patients 11 years and up Feb 12, 2024
Phenylephrine Sales Steady Before FDA Panel Called It Ineffective But reformulation of products containing OTC "decongestant" could affect the supply chain Feb 09, 2024
Publisher Retracts Three Abortion Studies Two of the studies were cited by a federal judge in the case against the abortion pill Feb 08, 2024
Resmetirom Poised to Become First NASH Treatment Phase III study demonstrated drug is effective in resolving NASH and improving liver fibrosis Feb 07, 2024